209
Participants
Start Date
March 7, 2019
Primary Completion Date
May 27, 2022
Study Completion Date
May 27, 2022
TAK-954 Placebo
TAK-954 placebo-matching intravenous infusion.
TAK-954
TAK-954 intravenous infusion.
Stony Brook University Hospital, Stony Brook
Penn State Health Milton S. Hershey Medical Center, Hershey
Universitaetsklinikum Hamburg-Eppendorf, Hamburg
University of South Alabama Medical Center, Mobile
Center for Colon & Rectal Surgery - Altamonte Springs, Orlando
University of Miami Leonard M. Miller School of Medicine, Miami
Cleveland Clinic Florida, Weston
University of Kentucky, Lexington
The Ohio State University Wexner Medical Center, Columbus
Fairview Hospital, Cleveland
Sankt Josef-Hospital, Bochum
Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
Universitatsklinikum Mannheim, Mannheim
Ochsner Medical Center, New Orleans
HD Research Corp., Houston
North Star Medical, Houston
Universitatsklinikum Freiburg, Freiburg im Breisgau
University of Colorado, Aurora
Klinikum Rechts der Isar der Technischen Universitat Munchen, München
Keck School of Medicine, Los Angeles
Cedars-Sinai Medical Center, Los Angeles
Parkview Community Hospital Medical Center, Riverside
University of California Irvine Medical Center, Orange
Universitaetsklinikum Regensburg, Regensburg
University of Massachusetts Memorial Medical Center, Worcester
Lead Sponsor
Takeda Development Center Americas, Inc.
INDUSTRY
Takeda
INDUSTRY